Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Deferred Taxes (2016 - 2019)

Historic Deferred Taxes for Assembly Biosciences (ASMB) over the last 4 years, with Q4 2019 value amounting to -$767000.0.

  • Assembly Biosciences' Deferred Taxes fell 16728.07% to -$767000.0 in Q4 2019 from the same period last year, while for Sep 2020 it was -$767000.0, marking a year-over-year decrease of 16928.64%. This contributed to the annual value of -$2.5 million for FY2021, which is N/A changed from last year.
  • According to the latest figures from Q4 2019, Assembly Biosciences' Deferred Taxes is -$767000.0, which was down 16728.07% from -$15000.0 recorded in Q3 2019.
  • Assembly Biosciences' 5-year Deferred Taxes high stood at $1.1 million for Q4 2018, and its period low was -$9.0 million during Q4 2017.
  • Over the past 4 years, Assembly Biosciences' median Deferred Taxes value was -$24500.0 (recorded in 2018), while the average stood at -$934848.7.
  • In the last 5 years, Assembly Biosciences' Deferred Taxes plummeted by 135543.43% in 2017 and then skyrocketed by 11267.43% in 2018.
  • Over the past 4 years, Assembly Biosciences' Deferred Taxes (Quarter) stood at -$618000.0 in 2016, then tumbled by 1355.43% to -$9.0 million in 2017, then surged by 112.67% to $1.1 million in 2018, then tumbled by 167.28% to -$767000.0 in 2019.
  • Its Deferred Taxes was -$767000.0 in Q4 2019, compared to -$15000.0 in Q3 2019 and -$11000.0 in Q2 2019.